Detection of Visual-Auditory Reaction Rates in Individuals With Type 2 Diabetes

February 10, 2023 updated by: melisa bilaloğlu, Baskent University

Background: The primary purpose of our study was to understand the damage in the peripheral nerves of patients with diabetes and to determine the change in patients' reaction rates and perceptions by the age groups, duration of diabetes, fasting plasma glucose and HbA1c values, and compare these with those of the healthy individuals.

Methods: This study was carried out at the Baskent University Hospital Endocrinology and Metabolic Diseases Outpatient Clinic. A total of 64 patients diagnosed with type 2 diabetes and 64 healthy controls were included in the study. Finger tapping, visual, and auditory reaction time tests were performed on the subjects, respectively. The subjects' fasting plasma glucose and HbA1c levels, and the duration of their diabetes were recorded. Analyses were performed using the SPSS version 25. Differences were considered statistically significant when the p-value is <0.05.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

128

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Ankara, Turkey
        • Baskent University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The study population consisted of healthy individuals aged between 18-64 years, diagnosed with type 2 diabetes, and resided in Ankara. The sample comprised 128 volunteers, 64 of whom were patients and 64 were controls.

Description

Inclusion Criteria:

  • Right-handed individuals
  • Must be between 18-65 ages
  • Must be Type 2 diabetics at least 6 months (for patient group)

Exclusion Criteria:

  • use of alcohol-drug or similar substances,
  • the use of any medication that may affect neurological functions,
  • having color blindness,
  • retinopathy,
  • neurological disease,
  • cancer,
  • depression,
  • a recent history of surgery,
  • rheumatoid arthritis,
  • osteoarthritis,
  • and advanced osteoarthritis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
DIABETES
Visual, finger tapping and auditory tests were performed regularly. The subjects' fasting plasma glucose and HbA1c levels, and the duration of their diabetes were recorded.
Device: recation time test
visual-finger tapping and auditory reaction time tests
CONTROL
Visual, finger tapping and auditory tests were performed regularly. The subjects' fasting plasma glucose and HbA1c levels were recorded.
Device: recation time test
visual-finger tapping and auditory reaction time tests

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Finger tap, visual and auditory reaction test data within 10 seconds
Time Frame: April-September 2021
Reaction times
April-September 2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Baskent University

Investigators

  • Study Chair: melisa bilaloğlu, res asst, Baskent University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 15, 2021

Primary Completion (ACTUAL)

August 15, 2021

Study Completion (ACTUAL)

September 14, 2021

Study Registration Dates

First Submitted

November 29, 2022

First Submitted That Met QC Criteria

February 10, 2023

First Posted (ACTUAL)

February 13, 2023

Study Record Updates

Last Update Posted (ACTUAL)

February 13, 2023

Last Update Submitted That Met QC Criteria

February 10, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 193.140.162.4

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 2

Clinical Trials on recation time test

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe